| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4075902
Max Phase: Preclinical
Molecular Formula: C23H35NO4
Molecular Weight: 389.54
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: C=C1C(=O)O[C@H]2[C@H]1CC/C(C(=O)N(CCCC)CCCC)=C\CC[C@@]1(C)O[C@@H]21
Standard InChI: InChI=1S/C23H35NO4/c1-5-7-14-24(15-8-6-2)21(25)17-10-9-13-23(4)20(28-23)19-18(12-11-17)16(3)22(26)27-19/h10,18-20H,3,5-9,11-15H2,1-2,4H3/b17-10+/t18-,19-,20-,23+/m0/s1
Standard InChI Key: YYPMGEDBJOLGLQ-VGQFNEPRSA-N
Associated Targets(Human)
KG-1a 249 Activities
HL-60 67320 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 389.54 | Molecular Weight (Monoisotopic): 389.2566 | AlogP: 4.17 | #Rotatable Bonds: 7 |
| Polar Surface Area: 59.14 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 0.42 | CX LogP: 4.55 | CX LogD: 4.55 |
| Aromatic Rings: 0 | Heavy Atoms: 28 | QED Weighted: 0.37 | Np Likeness Score: 1.84 |
References
| 1. Yang Z, Kuang B, Kang N, Ding Y, Ge W, Lian L, Gao Y, Wei Y, Chen Y, Zhang Q.. (2017) Synthesis and anti-acute myeloid leukemia activity of C-14 modified parthenolide derivatives., 127 [PMID:28068601] [10.1016/j.ejmech.2016.12.044] |
Source
Source(1):